PDL BioPharma (PDLI) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
General and administrative expenses: 10.4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative expenses: 10.4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $103.4 million versus the consensus estimate of $142.05 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
